Retour
42
Fourchette du Jour
25,43 €
26,31 €
Fourchette 52 Semaines
14,22 €
30,42 €
Volume
1 290 764
Moyenne 50J / 200J
26,27 €
/
21,87 €
Clôture Précédente
25,82 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 91,1 | 0,3 |
| P/B | 1,4 | 2,9 |
| ROE % | 1,6 | 3,7 |
| Net Margin % | 1,7 | 3,8 |
| Rev Growth 5Y % | 2,0 | 10,0 |
| D/E | 0,6 | 0,2 |
Objectif de Cours des Analystes
Hold
27,22 €
+4.6%
Low: 19,00 €
High: 35,00 €
P/E Prévisionnel
18,3
BPA Prévisionnel
1,41 €
Croissance BPA (est.)
+0,0%
CA Est.
2,8 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,89 €
1,87 € – 1,92 €
|
3,1 B | 1 |
| FY2028 |
1,73 €
1,16 € – 2,23 €
|
3 B | 3 |
| FY2027 |
1,56 €
1,52 € – 1,63 €
|
2,9 B | 10 |
Points Clés
Revenue grew 2,04% annually over 5 years — modest growth
ROE of 1,56% is below average
Generating 230,40M in free cash flow
P/E of 91,06 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,28%
Cash machine — converts 490,21% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
2,04%
Revenue (1Y)8,32%
Earnings (1Y)N/A
FCF Growth (3Y)2,92%
Qualité
Return on Equity
1,56%
ROIC3,52%
Net Margin1,73%
Op. Margin8,30%
Sécurité
Debt / Equity
0,55
Current Ratio2,38
Interest Coverage6,17
Valorisation
P/E Ratio
91,06
P/B Ratio1,38
EV/EBITDA21,16
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,32% | Revenue Growth (3Y) | 2,94% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2,04% | Earnings Growth (5Y) | -39,05% |
| Profitability | |||
| Revenue (TTM) | 2,72B | Net Income (TTM) | 47,00M |
| ROE | 1,56% | ROA | 0,83% |
| Gross Margin | 55,02% | Operating Margin | 8,30% |
| Net Margin | 1,73% | Free Cash Flow (TTM) | 230,40M |
| ROIC | 3,52% | FCF Growth (3Y) | 2,92% |
| Safety | |||
| Debt / Equity | 0,55 | Current Ratio | 2,38 |
| Interest Coverage | 6,17 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 91,06 | P/B Ratio | 1,38 |
| P/S Ratio | 1,57 | PEG Ratio | -0,74 |
| EV/EBITDA | 21,16 | Dividend Yield | 0,00% |
| Market Cap | 4,28B | Enterprise Value | 4,78B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,72B | 2,51B | 2,57B | 2,57B | 2,51B |
| Net Income | 47,00M | -1,12B | -100,20M | 243,10M | 340,50M |
| EPS (Diluted) | 0,28 | -6,50 | -0,60 | 1,34 | 1,48 |
| Gross Profit | 1,50B | 1,39B | 1,45B | 1,49B | 1,46B |
| Operating Income | 225,70M | -1,04B | 31,50M | 319,20M | 306,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,68B | 5,35B | 6,61B | 6,59B | 6,57B |
| Total Liabilities | 2,57B | 2,42B | 2,43B | 2,38B | 2,52B |
| Shareholders' Equity | 3,11B | 2,93B | 4,17B | 4,21B | 4,06B |
| Total Debt | 1,71B | 1,55B | 1,65B | 1,53B | 1,48B |
| Cash & Equivalents | 1,21B | 1,07B | 940,00M | 606,90M | 1,07B |
| Current Assets | 2,03B | 1,79B | 1,74B | 1,42B | 1,84B |
| Current Liabilities | 852,60M | 878,70M | 780,80M | 1,24B | 1,21B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#595 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026